Generic Medicine Info
Phaeochromocytoma, insulinoma, glucagonoma.
Special Precautions
Patient w/ adrenal insufficiency, DM (when used as diagnostic aid), cardiac disease, chronic hypoglycaemia, uraemia, hepatic disease. Childn. Pregnancy and lactation. Monitoring Parameters Monitor BP, serum glucose, ECG, heart rate, mentation; signs and symptoms of hypersensitivity reactions.
Adverse Reactions
Significant: Rarely, hypersensitivity reactions (e.g. anaphylactic shock, rash). CV: Hypotension, HTN, tachycardia, bradycardia. GI: Abdominal pain, diarrhoea, nausea, vomiting. Resp: Resp distress. Endocrine: Secondary hypoglycaemia, hypoglycaemic coma. Dermatologic: Rash, urticaria. Others: Hypokalaemia.
Drug Interactions
Beta blockers may cause greater increase in heart rate and BP. Insulin antagonises the effect of glucagon. Indomethacin may produce hypoglycaemia. May enhance the anticoagulant effect of warfarin. Anticholinergic drugs may increase GI reactions.
ATC Classification
H04AA01 - glucagon ; Belongs to the class of glycogenolytic hormones. Used in the treatment of hypoglycemia.
Disclaimer: This information is independently developed by CIMS based on glucagon from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in